These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1769475)

  • 41. [Biochemical characteristics of toxic hepatitis].
    Ishii H; Kato S; Ito D; Tsuchiya M
    Nihon Rinsho; 1985 Jun; 43(6):1139-43. PubMed ID: 2864460
    [No Abstract]   [Full Text] [Related]  

  • 42. [Recurrent cholestatic course of chronic aggressive hepatitis].
    Erb W; Siede W
    Dtsch Med Wochenschr; 1969 May; 94(22):1145-50. PubMed ID: 5768539
    [No Abstract]   [Full Text] [Related]  

  • 43. [Acute drug-induced hepatitis].
    Polunina TE
    Klin Med (Mosk); 1989 Oct; 67(10):87-90. PubMed ID: 2615317
    [No Abstract]   [Full Text] [Related]  

  • 44. Acute hepatitis due to brivudin: a case report.
    Mottu A; Rubbia-Brandt L; Bihl F; Hadengue A; Spahr L
    J Hepatol; 2009 Nov; 51(5):967-9. PubMed ID: 19692139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolonged viral hepatitis type A with cholestasis: case report.
    Schiraldi O; Modugno A; Miglietta A; Fera G
    Ital J Gastroenterol; 1991; 23(6):364-6. PubMed ID: 1742530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Liver damage caused by laxatives. A contribution to the hepatotoxicity of 4,4'-(2-quinolylmethylene)-diphenol-hydrochloride].
    Wiegelmann W; Borchard F; Irmscher K
    Arzneimittelforschung; 1975 Jun; 25(6):849-51. PubMed ID: 169854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic drug reactions.
    Perez V; Schaffner F; Popper H
    Prog Liver Dis; 1972; 4():597-625. PubMed ID: 4569012
    [No Abstract]   [Full Text] [Related]  

  • 48. [Liver damage after administration of pyrazinamide in animal experiments. 3. Biochemical changes in liver tissue and blood serum].
    Celikovská G; Stastná J; Zítková L; Brezinová H; Kürti V
    Arzneimittelforschung; 1970 Jan; 20(1):155-7. PubMed ID: 5467442
    [No Abstract]   [Full Text] [Related]  

  • 49. [Multivariant analysis of experimental liver damage: normal parameters of the rat serum].
    Rauen HM; Schriewer H; Gebauer B; Abu Tair M; Rüther N; The LG
    Arzneimittelforschung; 1973 Jan; 23():Suppl:108-16. PubMed ID: 4740676
    [No Abstract]   [Full Text] [Related]  

  • 50. [Evaluation of the functional state of the liver in acute pancreatitis using several enzyme tests].
    Synovets AS; Levitskiĭ AP; Michurin VF
    Klin Khir (1962); 1972 Jun; 6():4-8. PubMed ID: 5051059
    [No Abstract]   [Full Text] [Related]  

  • 51. Drug-induced liver injury: mechanisms, types and biomarkers.
    Vinken M; Maes M; Vanhaecke T; Rogiers V
    Curr Med Chem; 2013; 20(24):3011-21. PubMed ID: 23746274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug induced hepatitis.
    Quak SH
    J Singapore Paediatr Soc; 1991; 33(1-2):25-30. PubMed ID: 1784106
    [No Abstract]   [Full Text] [Related]  

  • 53. [Drug-induced reactions of infantile liver].
    Klinge O
    Monatsschr Kinderheilkd (1902); 1979 Mar; 127(3):115-8. PubMed ID: 423898
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hepatotoxicity of mianserin: a case with positive reintroduction].
    Barbare JC; Biour M; Cadot T; Latrive JP
    Gastroenterol Clin Biol; 1992; 16(5):486-8. PubMed ID: 1526410
    [No Abstract]   [Full Text] [Related]  

  • 55. Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine.
    Cheung WI; Tse ML; Ngan T; Lin J; Lee WK; Poon WT; Mak TW; Leung VK; Chau TN
    Clin Toxicol (Phila); 2009 Aug; 47(7):683-5. PubMed ID: 19640237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatotoxicity of mebendazole. Relationship with serum concentrations of the drug.
    Bekhti A; Pirotte J
    Gastroenterol Clin Biol; 1987 Oct; 11(10):701-3. PubMed ID: 3692093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the problem concerning the adaptation of the organism to repeated administration of a toxic agent in experiment.
    Vido I; Vido J
    Acta Hepatosplenol; 1965; 12(6):328-36. PubMed ID: 5868475
    [No Abstract]   [Full Text] [Related]  

  • 58. [Letter: Hepatitis medicamentosa caused by perhexiline].
    Beaugrand M
    Nouv Presse Med; 1976 Jul 3-10; 5(27):1695. PubMed ID: 958872
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cholestatic hepatitis induced by the prolonged administration of nalidixic acid (case report)].
    Rached-Mohassel MA; Hanjani AA; Nik-Akhtar B; Chariat C; Tabibi M
    Acta Med Iran; 1974 Aug; 17(1-2):47-56. PubMed ID: 4143406
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical and biopsy studies on the course of fatty liver hepatitis].
    Denk H; Leodolter I; Schnack H; Thaler H
    Wien Klin Wochenschr; 1970 Feb; 82(6):98-101. PubMed ID: 5513205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.